Airsonett is a Swedish Medtech company offering an effective home treatment for allergic diseases such as asthma and atopic dermatitis. Their patented TLA (Temperature-controlled Laminar Airflow) technology creates a 99.5% clean air zone around the patient’s breathing area during sleep, so the immune system and airways can rest and recuperate while you sleep.
Airsonett’s Air4 is a CE marked class 1 medical device, holding a 510(k) cleared class II approval from FDA and adheres to relevant EU directives regarding design, function, safety and health requirements and has undergone rigorous clinical research as well as health-economic studies.
